75 related articles for article (PubMed ID: 1841781)
1. [Cardiovascular therapy problems in the elderly patient].
Carbonin P; Bernabei R; Carosella L; Cocchi A; Menichelli P; Pahor M; Sgadari A; Zuccalà G
Cardiologia; 1991 Dec; 36(12 Suppl 1):275-9. PubMed ID: 1841781
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
4. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
5. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
[TBL] [Abstract][Full Text] [Related]
6. Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing.
Wyatt CM; Kim MC; Winston JA
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):102-9. PubMed ID: 16446779
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
Pede S; Lombardo M
Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular diseases in the elderly in a consultant outpatient cardiac clinic.
Antonelli D; Suleiman K; Turgeman Y
Isr Med Assoc J; 2009 Apr; 11(4):235-7. PubMed ID: 19603598
[TBL] [Abstract][Full Text] [Related]
9. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled intervention in cardiovascular drug treatment in nursing homes.
Ulfvarson J; Adami J; Ullman B; Wredling R; Reilly M; von Bahr C
Pharmacoepidemiol Drug Saf; 2003; 12(7):589-93. PubMed ID: 14558182
[TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic principles of cardiovascular drug administration to the critically ill.
Campbell S
Crit Care Clin; 1985 Nov; 1(3):471-90. PubMed ID: 3916790
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
15. [Side effects of cardiovascular drugs].
Koleva T; Madzharova Iu; Baleva V; Dragoĭcheva Ts; Stoĭkova K
Vutr Boles; 1989; 28(5):24-30. PubMed ID: 2618006
[TBL] [Abstract][Full Text] [Related]
16. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.
Garfinkel D; Zur-Gil S; Ben-Israel J
Isr Med Assoc J; 2007 Jun; 9(6):430-4. PubMed ID: 17642388
[TBL] [Abstract][Full Text] [Related]
17. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees.
Simon SR; Andrade SE; Ellis JL; Nelson WW; Gurwitz JH; Lafata JE; Davis RL; Feldstein A; Raebel MA
J Am Geriatr Soc; 2005 Dec; 53(12):2165-9. PubMed ID: 16398903
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions in patients with cardiovascular disease.
Faulx MD; Francis GS
Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular drugs and the older adult.
Potempa K; Roberts KV
Nurs Clin North Am; 1982 Jun; 17(2):263-74. PubMed ID: 6919936
[TBL] [Abstract][Full Text] [Related]
20. [Geriatric pharmacology. Pharmacokinetics and pharmacodynamics in the elderly. Problems with geriatric and nootropic drugs].
Turnheim K
Wien Klin Wochenschr; 1995; 107(12):349-56. PubMed ID: 7631505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
